Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

March 11, 2022

Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies

The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qu

C-Path and Tufts Medical Center Collaborate on EHR Data Transfer

The endeavor represents a major milestone for C-Path TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and

March 16, 2022

View Now | AI-powered Real-world Simulations for Faster and Value-based Rare Disease Drug Development

On March 16 Quinten Health CEO Billy Amzal, PhD, MBA, presented AI-powered Real-world Simulations for Faster and Value-base

March 7, 2022

eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain

C-Path Welcomes ActiGraph

C-Path is proud to welcome ActiGraph as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compr

March 2, 2022

Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies

eCOA Consortium Announces Publication of Open Access Article

C-Path’s eCOA Consortium is pleased to announce that “Measurement Comparability of Electronic and Paper Administration of Vi

February 23, 2022

Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials

C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based....

C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership

PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global nonprofit orga

January 31, 2022

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions

Previous5253 54...130 Next